Detalles de la búsqueda
1.
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.
Invest New Drugs
; 41(2): 267-275, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36792805
2.
A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors.
Invest New Drugs
; 40(1): 91-98, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34453241
3.
Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP).
Br J Clin Pharmacol
; 88(12): 5336-5347, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35831229
4.
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16).
BMC Cancer
; 21(1): 182, 2021 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33607966
5.
A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors.
Invest New Drugs
; 38(4): 1067-1076, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31471863
6.
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data.
BMC Cancer
; 19(1): 902, 2019 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31500588
7.
Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).
Cancer
; 124(7): 1449-1454, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29315500
8.
Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot study.
Gynecol Oncol
; 150(3): 471-477, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30060963
9.
Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.
BMC Urol
; 18(1): 81, 2018 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30236112
10.
Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom.
BMC Health Serv Res
; 18(1): 518, 2018 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29970078
11.
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.
Br J Haematol
; 176(5): 770-782, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27983764
12.
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).
BMC Cancer
; 17(1): 265, 2017 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407750
13.
Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation.
Hematol Oncol
; 35(4): 890-893, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27641727
14.
PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer.
Acta Oncol
; 56(12): 1734-1740, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28557585
15.
Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08).
Haematologica
; 101(3): 346-55, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26659919
16.
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.
BMC Cancer
; 16(1): 780, 2016 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27724870
17.
Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experience.
Support Care Cancer
; 24(5): 2119-2128, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553033
18.
Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer.
Support Care Cancer
; 24(8): 3557-65, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27022965
19.
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases.
Support Care Cancer
; 24(3): 1327-37, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26329397
20.
RANK ligand blockade with denosumab in combination with sorafenib in chemorefractory osteosarcoma: a possible step forward?
Oncology
; 88(4): 257-60, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25531914